JN Miami Valley Hospital
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Neurophysiol (November 22, 2006). doi:10.1152/jn.00963.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
97/1/883    most recent
00963.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ford, C.
Right arrow Articles by Williams, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford, C.
Right arrow Articles by Williams, J.
Submitted on September 8, 2006
Accepted on November 19, 2006

Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Post-Synaptic Currents

Chris Ford1, Michael Beckstead2, and John Williams3*

1 Vollum, OHSU, Portland, Oregon, United States; Vollum - OHSU, 3181 SW Sam Jackson Park Rd., Portland, Oregon, 97210, United States
2 OHSU; OHSU, United States
3 John Williams, Volum Inst., OHSU, Vollum, portland, Oregon, 97239, United States; Vollum Insitute, OHSU, portland, Oregon, United States; John Williams, John Williams, United States

* To whom correspondence should be addressed. E-mail: williamj{at}ohsu.edu.

In the midbrain, dopamine neurons can release dopamine somatodendritically. This results in an inhibitory post-synaptic current (IPSC) within adjacent dopamine cells that occurs via the activation of inhibitory D2 autoreceptors. Kappa, but not mu/delta opioid receptors inhibit this IPSC. The aim of the present study was to determine the mechanism by which kappa-opioid receptors inhibit the dopamine IPSC. In both the Ventral Tegmental Area (VTA) and Substantia Nigra Compacta (SNc) the kappa-receptor agonist, U69593 inhibited the IPSC, but not the current induced by the exogenous iontophoretic application of dopamine. The endogenous peptide, dynorphin A (1-13) also inhibited IPSCs in the VTA and SNC and the current caused by dopamine iontophoresis in the VTA. Although both kappa agonists induced a postsynaptic outward current in the VTA, the current induced by dynorphin was dramatically larger. This suggests that the decrease in iontophoretic dopamine current was the result of occlusion. Occlusion alone could not however completely account for suppression of the IPSC. The kappa opioid inhibition of the IPSC was not affected by global increases or decreases in dopamine cell activity within the slice. These findings suggest that while kappa opioid receptors can hyperpolarize dopamine neurons, they also suppress dopamine release via direct actions at the release site. The results thus demonstrate both pre- and postsynaptic actions of kappa receptor agonists. The actions of dynorphin indicate that VTA dopamine cells are selectively regulated by kappa receptors.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. P. Britt and D. S. McGehee
Presynaptic Opioid and Nicotinic Receptor Modulation of Dopamine Overflow in the Nucleus Accumbens
J. Neurosci., February 13, 2008; 28(7): 1672 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Cs. Horvath, G. G. Kovacs, V. Kovari, K. Majtenyi, Y. L. Hurd, and E. Keller
Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age
J. Neurosci., December 5, 2007; 27(49): 13371 - 13375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the The American Physiological Society.